|
| Status |
Public on Feb 08, 2021 |
| Title |
S1PR3–G12-biased agonist ALESIA targets cancer metabolism and promotes glucose starvation |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| Web link |
https://0-www-sciencedirect-com.brum.beds.ac.uk/science/article/pii/S2451945621000040
|
| |
|
| Citation(s) |
33561428 |
| Submission date |
Jan 14, 2020 |
| Last update date |
Feb 12, 2021 |
| Contact name |
Kei IIDA |
| E-mail(s) |
kiida@life.kindai.ac.jp
|
| Organization name |
Kindai University
|
| Street address |
Kowakae 3-4-1
|
| City |
Higashi-Osaka |
| State/province |
Osaka |
| ZIP/Postal code |
5778502 |
| Country |
Japan |
| |
|
| Platforms (2) |
| GPL17303 |
Ion Torrent Proton (Homo sapiens) |
| GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
| Samples (12)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE111352 |
S1PR3–G12-biased agonist ALESIA targets cancer metabolism and promotes glucose starvation [MCF-7 RNA-seq] |
| GSE143668 |
S1PR3–G12-biased agonist ALESIA targets cancer metabolism and promotes glucose starvation [HeLa RNA-seq] |
|
| Relations |
| BioProject |
PRJNA601208 |
Less...
More...